AXYS Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CYBERKEN who wrote (14)	1/11/1998 6:11:00 PM
From: Andrew H	Read Replies (1) of 455

From an email I received. The rec unfortunately comes from Michael Murphy. I would be a lot happier if it were from someone else. 28 by year end tells me he still has his head in the clouds. Still, it is hopeful. I like the part about "the best drug discovery company out there." >>Arris Pharmaceutical (Nasdaq: ARRS), based in South San Francisco, California, is a young biotech company that is poised to merge with Sequana Therapeutics (Nasdaq: SQNA), a genetic-research company. The deal to merge has already been signed; the new company will be known as AxyS (each share of Arris will get you a share of AxyS). This new outfit quite possibly will be the best drug-discovery company out there, and it will have superb partnerships: Arris's with Bayer and Sequana's with the leading German pharmaceutical company, Boerhinger Ingelheim. Moreover, the Hambrecht & Quist biotech conference takes place in January and should bring a lot of attention to the new company. I expect AxyS's stock to trade at $28 a share by the end of the year and to top $100 a share by the year 2000-or as soon as one of the company's drugs is approved.<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next